Pelofen, a novel microtubule stabilizing agent for second-line treatment strategies in multidrug resistant oncology patients
Implementation of a care pathway for raising adequate, self-management of patients with cancer receiving oral anticancer drugs prescribed
Application of enzyme substrate analogues: from inhibitors with anti-mycobacterial properties to synthetic genetic polymers
Rapid detection of Mycobacterium tuberculosis resistance to second-line drugs by use of the manual mycobacterium growth indicator tube system
High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia
Implications of failure to routinely diagnose resistance to second-line drugs in patients with rifampicin-resistant tuberculosis on Xpert MTB/RIF
High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia